If the 21st Century Cures Act is the law one provision is that the FDA can permit some treatments to be marketed after phase 2 studies are completed. I don't know if Kerastem would meet the requirements but if it does then the FDA might allow it to be marketed after phase 2. Final results for phase 2 will be released later this year so if the FDA allows early marketing for Kerastem then it could hit the market by mid 2018 or thereabouts.